These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 16204178)

  • 1. Membrane organization and tumorigenesis--the NF2 tumor suppressor, Merlin.
    McClatchey AI; Giovannini M
    Genes Dev; 2005 Oct; 19(19):2265-77. PubMed ID: 16204178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact-dependent inhibition of EGFR signaling by Nf2/Merlin.
    Curto M; Cole BK; Lallemand D; Liu CH; McClatchey AI
    J Cell Biol; 2007 Jun; 177(5):893-903. PubMed ID: 17548515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2.
    Wiederhold T; Lee MF; James M; Neujahr R; Smith N; Murthy A; Hartwig J; Gusella JF; Ramesh V
    Oncogene; 2004 Nov; 23(54):8815-25. PubMed ID: 15467741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas.
    Lallemand D; Manent J; Couvelard A; Watilliaux A; Siena M; Chareyre F; Lampin A; Niwa-Kawakita M; Kalamarides M; Giovannini M
    Oncogene; 2009 Feb; 28(6):854-65. PubMed ID: 19029950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.
    Lallemand D; Saint-Amaux AL; Giovannini M
    J Cell Sci; 2009 Nov; 122(Pt 22):4141-9. PubMed ID: 19910496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCC regulates cell adhesion in human colon cancer derived HT-29 cells and associates with ezrin.
    Martín M; Simon-Assmann P; Kedinger M; Martin M; Mangeat P; Real FX; Fabre M
    Eur J Cell Biol; 2006 Aug; 85(8):769-83. PubMed ID: 16762451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular transformation by a FERM domain mutant of the Nf2 tumor suppressor gene.
    Johnson KC; Kissil JL; Fry JL; Jacks T
    Oncogene; 2002 Sep; 21(39):5990-7. PubMed ID: 12203111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
    Laulajainen M; Muranen T; Carpén O; Grönholm M
    Oncogene; 2008 May; 27(23):3233-43. PubMed ID: 18071304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin.
    Muranen T; Grönholm M; Renkema GH; Carpén O
    Oncogene; 2005 Feb; 24(7):1150-8. PubMed ID: 15580288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions.
    Lallemand D; Curto M; Saotome I; Giovannini M; McClatchey AI
    Genes Dev; 2003 May; 17(9):1090-100. PubMed ID: 12695331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumour suppressor protein NF2/merlin: the puzzle continues.
    Hovens CM; Kaye AH
    J Clin Neurosci; 2001 Jan; 8(1):4-7. PubMed ID: 11148074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
    Muranen T; Grönholm M; Lampin A; Lallemand D; Zhao F; Giovannini M; Carpén O
    Hum Mol Genet; 2007 Jul; 16(14):1742-51. PubMed ID: 17566081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function.
    Surace EI; Haipek CA; Gutmann DH
    Oncogene; 2004 Jan; 23(2):580-7. PubMed ID: 14724586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.
    Koga H; Araki N; Takeshima H; Nishi T; Hirota T; Kimura Y; Nakao M; Saya H
    Oncogene; 1998 Aug; 17(7):801-10. PubMed ID: 9779996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac.
    Morrison H; Sperka T; Manent J; Giovannini M; Ponta H; Herrlich P
    Cancer Res; 2007 Jan; 67(2):520-7. PubMed ID: 17234759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the tumor suppressor genes NF2, 4.1B, and TSLC1 in canine meningiomas.
    Dickinson PJ; Surace EI; Cambell M; Higgins RJ; Leutenegger CM; Bollen AW; LeCouteur RA; Gutmann DH
    Vet Pathol; 2009 Sep; 46(5):884-92. PubMed ID: 19429976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF2: the wizardry of merlin.
    Xiao GH; Chernoff J; Testa JR
    Genes Chromosomes Cancer; 2003 Dec; 38(4):389-99. PubMed ID: 14566860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Merlin inhibits growth hormone-regulated Raf-ERKs pathways by binding to Grb2 protein.
    Lim JY; Kim H; Jeun SS; Kang SG; Lee KJ
    Biochem Biophys Res Commun; 2006 Feb; 340(4):1151-7. PubMed ID: 16405865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of mutations in Drosophila melanogaster tumor suppressor Merlin on proliferation and differentiation of wing cells].
    Dubatolova TD; Kopyl SA; Bulgakova NA; Dorogova NV; Omel'ianchuk LV; Chang L-
    Genetika; 2010 Feb; 46(2):187-93. PubMed ID: 20297652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization to the cortical cytoskeleton is necessary for Nf2/merlin-dependent epidermal growth factor receptor silencing.
    Cole BK; Curto M; Chan AW; McClatchey AI
    Mol Cell Biol; 2008 Feb; 28(4):1274-84. PubMed ID: 18086884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.